Kyongbo Pharmaceutical Co., Ltd (KRX:214390)

Kyongbo Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	170,217	137,943	148,701	200,579	239,069	256,999
Market Cap Growth	13.02%	-7.23%	-25.86%	-16.10%	-6.98%	-34.25%
Enterprise Value	288,840	257,424	236,571	278,339	290,819	317,767
Last Close Price	7120.00	5770.00	6166.38	8261.77	9788.34	10462.95
PE Ratio	933.75	756.70	32.05	67.44	391.54	-
PS Ratio	0.64	0.52	0.62	0.93	1.22	1.51
PB Ratio	1.17	0.95	1.02	1.39	1.66	1.76
P/TBV Ratio	1.20	0.97	1.05	1.43	1.70	1.81
P/FCF Ratio	-	-	-	-	-	556.60
P/OCF Ratio	22.83	18.50	997.21	41.41	23.61	14.30
EV/Sales Ratio	1.09	0.98	0.99	1.29	1.48	1.86
EV/EBITDA Ratio	13.84	15.39	10.35	16.14	21.82	51.82
EV/EBIT Ratio	37.66	73.16	22.63	50.20	208.82	-
EV/FCF Ratio	-8.47	-	-	-	-	688.22
Debt / Equity Ratio	0.87	0.87	0.63	0.53	0.45	0.39
Debt / EBITDA Ratio	7.57	7.57	4.00	4.40	4.84	9.23
Debt / FCF Ratio	-	-	-	-	-	122.55
Net Debt / Equity Ratio	0.81	0.81	0.58	0.49	0.40	0.36
Net Debt / EBITDA Ratio	7.09	7.09	3.73	4.09	4.30	8.53
Net Debt / FCF Ratio	-3.48	-3.48	-6.80	-14.56	-20.86	113.26
Asset Turnover	0.88	0.88	0.87	0.85	0.82	0.70
Inventory Turnover	1.89	1.89	1.85	2.40	2.65	2.27
Quick Ratio	0.49	0.49	0.44	0.53	0.61	0.59
Current Ratio	1.08	1.08	1.15	1.15	1.22	1.25
Return on Equity (ROE)	0.13%	0.13%	3.19%	2.07%	0.42%	-4.97%
Return on Assets (ROA)	0.73%	0.73%	2.38%	1.37%	0.36%	-1.69%
Return on Invested Capital (ROIC)	0.54%	0.58%	4.43%	2.67%	0.70%	-3.34%
Return on Capital Employed (ROCE)	2.00%	2.00%	6.90%	3.70%	1.00%	-4.50%
Earnings Yield	0.11%	0.13%	3.12%	1.48%	0.26%	-2.92%
FCF Yield	-20.02%	-24.71%	-8.44%	-2.42%	-1.15%	0.18%
Payout Ratio	655.72%	655.72%	25.77%	40.19%	195.77%	-
Buyback Yield / Dilution	4.71%	4.71%	-0.03%	-1.80%	1.62%	0.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.